News
05-24-2012, 01:13 AM
A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers...
More... (http://www.medicalnewstoday.com/releases/245717.php)
More... (http://www.medicalnewstoday.com/releases/245717.php)